Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.

Noh, J Y; Asari, T; Hamada, N; Makino, F; Ishikawa, N; Abe, Y; Ito, K; Ito, K

Noh, J Y; Asari, T; Hamada, N; Makino, F; Ishikawa, N; Abe, Y; Ito, K; Ito, K.

Affiliation

Noh JY; Ito Hospital, Tokyo, Japan.

Clin Endocrinol (Oxf) ; 54(5): 651-4, 2001 May.

Article in En | MEDLINE | ID: mdl-11380496

Subject(s)

Antibodies, Antineutrophil Cytoplasmic/blood; Antithyroid Agents/therapeutic use; Graves Disease/immunology; Peroxidase/immunology; Propylthiouracil/therapeutic use; Vasculitis/chemically induced; Adolescent; Adult; Aged; Antithyroid Agents/adverse effects; Biomarkers/blood; Child; Female; Graves Disease/drug therapy; Humans; Male; Middle Aged; Propylthiouracil/adverse effects; Time Factors; Vasculitis/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Propylthiouracil / Antithyroid Agents / Vasculitis / Graves Disease / Peroxidase / Antibodies, Antineutrophil Cytoplasmic Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Clin Endocrinol (Oxf) Year: 2001 Document type: Article

Search on Google

XML

PubMed Links